Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 11/20 | 0.45 |
| ▸ | TACR3 | P29371 | 11/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.44 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5447117 | 0.90 | TACR2 (0.55) | TACR2TACR3OPRM1IDO1TRPV4 | |
| SCHEMBL5746603 | 0.83 | TACR2 (0.52) | TACR2TACR3OPRM1NTRK1IDO1 | |
| SCHEMBL5442143 | 0.82 | TACR2 (0.66) | TACR2TACR3OPRM1TRPV4CYP2C9 | |
| SCHEMBL5744608 | 0.81 | TACR2 (0.55) | TACR2TACR3OPRM1NTRK1TRPV4 | |
| SCHEMBL5747216 | 0.80 | TACR2 (0.54) | TACR2TACR3OPRM1NTRK1TRPV4 | |
| SCHEMBL6201232 | 0.80 | TACR3 (0.46) | TACR2TACR3OPRM1NTRK1IDO1 | |
| SCHEMBL5744442 | 0.79 | TACR2 (0.47) | TACR2TACR3OPRM1NTRK1MAPT | |
| SCHEMBL6200585 | 0.79 | TACR2 (0.47) | TACR2TACR3OPRM1NTRK1MAPT | |
| SCHEMBL5454432 | 0.77 | DHODH (0.54) | DHODH | |
| SCHEMBL6249567 | 0.76 | TACR2 (0.46) | TACR2TACR3OPRM1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1377567-B1 | QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS | GLAXOSMITHKLINE SPA (IT) | 2005-12-21 | — | — | EP | claimed |